Upregulation of the expression of RANKL on osteoclastogenesis-supporting cells, downregulation of OPG expression or increased secretion of factors activating RANK receptor signaling have all been described in the context of breast cancer bone metastases (Kearns et al., 2008). The gene discussed is TNFRSF11B; the disease is breast carcinoma.